Page last updated: 2024-08-24

geranylgeraniol and Anterior Circulation Transient Ischemic Attack

geranylgeraniol has been researched along with Anterior Circulation Transient Ischemic Attack in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Endres, M; Huang, P; Huang, Z; Laufs, U; Liao, JK; Moskowitz, MA; Nakamura, T	1

Other Studies

1 other study(ies) available for geranylgeraniol and Anterior Circulation Transient Ischemic Attack

Article	Year
Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proceedings of the National Academy of Sciences of the United States of America, 1998, Jul-21, Volume: 95, Issue:15 Topics: Animals; Anticholesteremic Agents; Cells, Cultured; Diterpenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Lovastatin; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Simvastatin; Tumor Cells, Cultured; Up-Regulation	1998

Article

Year

Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase.

Proceedings of the National Academy of Sciences of the United States of America, 1998, Jul-21, Volume: 95, Issue:15

Topics: Animals; Anticholesteremic Agents; Cells, Cultured; Diterpenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Lovastatin; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Simvastatin; Tumor Cells, Cultured; Up-Regulation

1998